Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Apply
BI-1808 & Pembrolizumab
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step